CN105543125B - One plant of jute streptomycete for producing jinggangmeisu and its application - Google Patents

One plant of jute streptomycete for producing jinggangmeisu and its application Download PDF

Info

Publication number
CN105543125B
CN105543125B CN201510963611.0A CN201510963611A CN105543125B CN 105543125 B CN105543125 B CN 105543125B CN 201510963611 A CN201510963611 A CN 201510963611A CN 105543125 B CN105543125 B CN 105543125B
Authority
CN
China
Prior art keywords
jinggangmeisu
fermentation
bacterial strain
content
seed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510963611.0A
Other languages
Chinese (zh)
Other versions
CN105543125A (en
Inventor
夏建荣
程治国
王梦婕
周莉
邹维
龚永华
万俊
金海燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan Kernel Bio Tech Co ltd
Original Assignee
Wuhan Kernel Bio Tech Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan Kernel Bio Tech Co ltd filed Critical Wuhan Kernel Bio Tech Co ltd
Priority to CN201510963611.0A priority Critical patent/CN105543125B/en
Publication of CN105543125A publication Critical patent/CN105543125A/en
Application granted granted Critical
Publication of CN105543125B publication Critical patent/CN105543125B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/46Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses jute streptomycete (Streptomyces corchorusii) KN-1625 that one plant produces jinggangmeisu, are deposited in China typical culture collection center, and deposit number is CCTCC NO:M2015710.The bacterium can improve the content of jinggangmycin A in jinggangmeisu fermentation liquid, reduce the content of jinggangmeisu B, compared with starting strain, jinggangmycin A content, which improves 47%, B/A, reduces 37.56%.And jinggangmeisu stable yield, more than 30000 μ g/mL, the genetic stability of KN-1625 bacterial strain is good, and it is suitable with the first generation to reach four generations production jinggangmeisu level.

Description

One plant of jute streptomycete for producing jinggangmeisu and its application
Technical field
The invention belongs to field of biotechnology, and in particular to the jute streptomycete of one plant of production jinggangmeisu (Streptomyces corchorusii), the invention further relates to the applications of the bacterial strain.
Background technique
Jinggangmeisu is a kind of farm antibiotics, can effectively prevent banded sclerotial blight, is " preventive effect is high, without phytotoxicity, pollution-free " Eco-friendly pesticide is current yield and the maximum farm antibiotics of usable floor area.Jinggangmeisu belongs to aminoglycoside, mainly by A, the groups such as B, C, D, E, F are grouped as, and find the compositions such as G and H again later, but only component A is most strong to the preventive and therapeutic effect of banded sclerotial blight, High-content jinggangmycin A acts not only as Pesticide use, is also used as the intermediate of production medicine, application prospect is very It is wide.However the jinggangmeisu impurity content at present using microbial fermentation processes production is higher, especially jinggangmeisu B's contains Amount is higher, and product quality is generally poor.
Summary of the invention
The purpose of the present invention is by jute streptomyces strain carry out induced mutations, thus obtain one plant can be used not only for giving birth to Jinggangmeisu is produced, and jinggangmycin A content can be improved, reduces the jute streptomycete of jinggangmeisu B content.
Applicant for starting strain, is used 1000Gy dosage 60CO- gamma-rays to carry out with jute streptomycete (KN-11) First round mutagenesis, obtains one plant of KN-16 bacterial strain, which is higher by than the potency (content for producing jinggangmycin A) of starting strain 21%, the second wheel mutagenesis then is carried out to KN-16 bacterium with ultraviolet light again, obtains one plant of KN-162 bacterial strain, the potency than KN-16 mentions It is high by 9.8%.KN-162 bacterial strain is subjected to resistance screening again, it should with the low own metabolism object processing of high-purity, impurity content Bacterial strain kills or resists the breeding of many cells big absolutely, selects the anti feedback mutant strain for largely generating the metabolin, obtain 1 plant Direct mutation KN-1625 bacterial strain, the content ratio KN-162 bacterial strain which produces jinggangmycin A is high by 18%, produces containing for jinggangmeisu B/A Amount lower than KN-162 bacterial strain about 37.56%.
The bacterial strain is identified as jute streptomycete (Streptomyces corchorusii), is named as KN-1625, application The bacterium is preserved in the China typical culture collection in the Wuhan University of Wuhan City, Hubei Province on November 26th, 2015 by people Center (CCTCC), deposit number are CCTCC NO:M 2015710.
The performance of jinggangmeisu is produced for verifying KN-1625 bacterium, KN-1625 bacterial strain is put into production and carried out by applicant The pilot scale research of two batches first activates KN-1625 bacterial strain, and the bacteria suspension after activation carries out secondary seed culture, training Nutrient solution enters back into fermentor and ferments, and is detected with high performance liquid chromatography to fermentation liquid after putting tank, the results showed that:Fermentation The content of jinggangmycin A is up to 3.065% in liquid, and the content ratio (B/A) of jinggangmeisu B and jinggangmycin A is only 11.52%, Compared with starting strain (KN-11), jinggangmycin A content, which improves 47.00%, B/A, reduces 37.56%, and jinggangmeisu Stable yield also increases more than 30000 μ g/mL, than CK bacterial strain.Test result is also shown that the heredity of KN1625 bacterial strain is steady It is qualitative good, it is suitable with the first generation to reach four generations production jinggangmeisu level.
Specific embodiment
The present invention is described in detail below in conjunction with specific embodiment.
The mutagenesis and screening of 1 bacterial strain of embodiment
1. using 60CO- gamma-rays processing bacteria suspension to obtain mutant strain
The inclined-plane cell or appropriate spore for taking jute streptomycete KN-11, are placed in the sterile water containing bead, keep it thin Born of the same parents or spore concentration sufficiently shake up and break up in 106~108/milliliter.Since γ firing line penetration capacity is very strong, cell is caused Dead effect is more stronger than general chemical mutagen.Induced dosage, which rests in lethality 90-99%, to be advisable, and is to set out with KN-16 Bacterial strain, by its spore bacteria suspension various dose 60CO- gamma-ray irradiation, dosage 300Gy, 500Gy, 700Gy, 1000Gy, When 1300Gy, 1500Gy, dead rate of making a speech respectively is 75.7%, 85.3%, 89.1%, 95.0%, 98.2%, 99.10%. What processing spore death rate rose in 300Gy is very fast, and it is relatively slow that 500-1500Gy handles the variation of spore death rate.
Induced dosage is different, also different to the mutation rate of KN-11.Induced dosage is excessive, and direct mutation is very low, by 700Gy, Bacteria suspension dilution after 1000Gy, 1300Gy, 1500Gy mutagenesis carries out plate count, is added 2 milliliters in the bacterial plaque after mutagenesis Sterile water is impregnated 0.5 hour, purges bacterial plaque repeatedly with 1 milliliter of pipettor and be transferred in sterile test tube afterwards for several times, managed with this and be 10-1 pipe, takes turns doing 10 times of dilution spreads.28 DEG C constant temperature incubation 5 days, observe growing way, choosing colony diameter is big, growing way is fast, water suction Fast, the full intermediate projections of lawn bacterium colonies carry out shaking flask screening, and one plant of KN-16 bacterial strain is obtained in 1000Gy Induced dosage, For yield compared with starting strain (KN-11), potency is higher by 21%.
2. using ultraviolet mutagenesis processing screening mutant strain, to obtain the bacterial strain of a small number of function admirables
Bacterial strain after 60CO- gamma-ray and mutagenesis, most cells are dead, but there have the DNA in a few cell to occur to be prominent Become, the bacterial strain after these are mutated carries out ultraviolet mutagenesis again, can influence the repair of DNA damage, is allowed to occur more Mistake, improve induced mutation rate, mutagenic frequency is high and is not easy to reply, and ultraviolet light can cause the DNA mutation of microbial cells, is formed Pyrimidine dimer.Illumination will disconnect dimer, so ultraviolet light carries out under the conditions of being protected from light when luring.Have previously been thought that lethality exists 90-99.9% effect is good.But current report thinks that lethality is conducive to the generation of direct mutation type in 70-80%, and screens Bacterial strain genetic stability it is good.
10 × 108/ml monospore suspension is made in KN-16 bacterium, is taken in the aseptic flat board that 2ml is 90mm to diameter, Ultraviolet mutagenesis (wavelength 253.7nm, power 15W, irradiation distance 30cm) is carried out under magnetic agitation, irradiation time is respectively 0,2, 5,8,10,15,20,25min, then take 28 DEG C of constant temperature on the bacteria suspension 0.1mL to plating medium by various dose irradiation Culture 5 days, carries out count plate, and draw destruction curve after bacterium colony is grown, after obtaining destruction curve, is existed with lethality The irradiation time of 80-90% irradiates bacterial strain, again 28 DEG C constant temperature incubation 5 days.Lethality is diluted and applied in the bacterial strain of 90-95% On cloth to the bacterial strain containing maximum tolerance jinggangmycin A concentration, 28 DEG C constant temperature incubation 5 days, by the bacterium colony number shaking flask grown survey Determine the content of jinggangmycin A and the content of B component, obtain one plant of KN-162 bacterial strain, shaking flask ratio KN-16 bacterial strain produces jinggangmycin A Content is high by 9.8%.
3. obtaining the low bacterial strain of high yield jinggangmycin A, B component by resistance screening
Jinggangmycin A is aminoglycoside antibiotics, is the secondary metabolite of actinomyces, and metabolic pathway is complicated, grinds Study carefully show antibiotic fermentation by feedback inhibition clearly, especially aminoglycoside antibiotics.Secondary metabolite is certain One kind that biology generates in order to avoid detrimental effect caused by intermediate accumulations certain during primary metabolite is advantageous In the metabolic type of existence.Since cometabolism and primary metabolite have common point poor intermediate, primary metabolite can be both synthesized Product, and secondary metabolite can be synthesized.When nutriment is unbalanced in the environment of thalli growth, i.e., certain nutrition Surplus, certain nutritional deficiency, thallus cannot effectively take in nutrition, under the action of metabolic system, the decline of growth and breeding rate, And superfluous nutriment is transformed by the secondary metabolite unrelated with growth and breeding by the change of metabolic pathway.Therefore, In bacterium, we just to eliminate feedback regulation of the metabolite to those common intermediates, are allowed to largely accumulate, It is advantageous for the synthesis of jinggangmycin A in this way, reduces impurity content.
KN-162 bacterial strain is subjected to resistance screening again, is low itself of 18% impurity content with 64A high-purity, B/A Metabolin jinggangmycin A (standard items) is put into growth training by various concentration (effective content 0.2,0.4,0.6,0.8,1.0,1.2) Support and co-cultured in base, to kill or resist the breeding of many cells big absolutely, select largely generate the metabolin anti feedback it is prominent Mutant.0.1ml is taken to be coated on the anti-plate of 4.0A after bacterium solution is diluted suitable concentration, 37 DEG C are cultivated 5-6 days, and picking 100 prominent Mutant expands on normal inclined-plane, screens by shake flask fermentation, obtains 1 plant of positive mutating strain KN-1625 bacterial strain, which produces Jing Gang The content ratio KN-162 bacterial strain of mycin A is high by 18%, produces the content ratio KN-162 bacterial strain low about 37.56% of jinggangmeisu B.
4. the identification of bacterial strain
The bacterial strain starting strain be jute streptomycete, gram-positive bacteria, after complex mutation, the strain morphology spore Silk spiral shape, spore oval, surface is smooth, and bacterium colony is Slate grey, and pigment penetrates in culture medium, and base silk is dark brown, gas silk Slate grey.Form is identical as starting strain, does not occur the change of Pseudomonas, and bacterial strain is identified still as jute streptomycete.
5. the genetic stability of bacterial strain
Improvement strain KN-1625 is connect into inclined-plane and carries out passage assays, to examine the genetic stability of improved strain, through passing 4 Show that the strain stability is good for confirmatory experiment.
The mitotic stability of 1 KN-1625 bacterial strain of table is examined
Data show that it is suitable with the first generation that KN-1625 bacterial strain reaches four generations production jinggangmeisu level, it was demonstrated that bacterial strain heredity Stablize, can be used as engineering bacteria and put into production.
Embodiment 2 produces the experimental study of jinggangmeisu using bacterial strain
1) bacterial strain activates
The KN-1625 bacterial strain of preservation is activated on Gause I slant medium, 28 DEG C are cultivated 7 days, will with sterile water Lawn is washed down, and seed bacteria suspension is obtained;
2) secondary seed culture
Seed bacteria suspension obtained by step 1) is accessed into seed fermentation tank, 200rpm, 40 DEG C of culture 16-18hr, seed fermentation Medium component is:Rice meal 4.66%, corn flour 2.52%, dregs of beans 1.033%, NaCl 0.03%, CaCO3 0.05%, KH2PO4 0.03%, surplus are water, and the content of each ingredient presses mass volume ratio;
3) fermented and cultured
The seed fermentation liquid obtained after step 2) fermentation is moved into bulk fermentation tank and is cultivated, setting fermentation parameter is:It is logical Gas is than 1:1, mixing speed 420rpm, 40 DEG C of fermentation temperature, incubation time 30-32hr is obtained after putting tank containing jinggangmeisu The ingredient of fermentation liquid, fermentation medium is:Rice meal 6.5%, starch 4%, corn flour 2.5%, dregs of beans 2.5%, NaCl 0.03%, CaCO3 0.03%, KH2PO4 0.03%, defoaming agent 0.01%, surplus are water, and the defoaming agent is XP-100F system Column fermentation organic silicon defoamer, the content of each ingredient press mass volume ratio.
4) the HPLC detection of tank effective content and impurity content is put
HPLC testing conditions
Mobile phase:0.05mol/L disodium hydrogen phosphate-methanol=97 phosphoric acid (PH7.0):3
Chromatographic column:TC-C18/5.8 200X4.6mm
Detector:Ultraviolet 210nm
Flow velocity:1.0ml.min-1
Retention time:About 5.0min
By jinggangmycin A standard items be made into 25,50,75,100, the standard solution of five kinds of different contents of 125ug/ml, It determines and is examined under chromatographic condition, be that ordinate draws working curve using jinggangmycin A amount as abscissa, peak area, obtain a line The good straight line of sexual intercourse, equation of linear regression Y=7.6196X+36.675, suitable coefficients R 2=0.9995.Illustrate that well ridge is mould Plain A concentration in 25~125ug/ml range, peak area and jinggangmycin A is dense cross between have good linear relationship.
5) data are analyzed
The standard sample spectrum of 3 kinds of concentration is recalled in chromatographic work station, carries out calibrated, drafting standard curve.According to jinggangmeisu A, the content ratio of the calculated by peak area B/A of B, while according to the content of control and standard curve calculating jinggangmycin A, detect two batches The data of secondary production, while being control with starting strain, as a result it see the table below.
Liquid phase peak area and the data statistics of 2 KN-1625 bacterial strain of table and control strain
It is shown by 2 data of table, jinggangmycin A content average out to 2.085% in the fermentation liquid of CK bacterial strain production, B/A is average It is 18.45%;Jinggangmycin A content average out to 3.065 in the fermentation liquid of KN-1625 bacterial strain production, B/A average out to 11.52%; The jinggangmycin A content ratio CK bacterial strain of KN-1625 bacterial strain, which improves 47.00%, B/A, reduces 37.56%.
The jinggangmeisu stable yield of KN-1625 bacterial strain production also increases more than 30000 μ g/mL than CK bacterial strain.

Claims (4)

1. jute streptomycete (Streptomyces corchorusii) KN-1625 of one plant of production jinggangmeisu, is deposited in China Type Tissue Collection, deposit number are CCTCC NO:M 2015710.
2. application of the jute streptomycete KN-1625 described in claim 1 in jinggangmeisu production.
3. a kind of jinggangmeisu production method, it is characterised in that:It is hair with jute streptomycete KN-1625 described in claim 1 Yeast-like fungi strain.
4. jinggangmeisu production method as claimed in claim 3, it is characterised in that include the following steps:
1) bacterial strain activates:The jute streptomycete KN-1625 bacterial strain is activated on Gause I slant medium, 28 DEG C of cultures 7 days, lawn is washed down with sterile water, obtains seed bacteria suspension;
2) secondary seed culture:Seed bacteria suspension is accessed into seed fermentation tank, 200rpm, 40 DEG C of 16~18hr of culture, seed hair Ferment medium component is:Rice meal 4.66%, corn flour 2.52%, dregs of beans 1.033%, NaCl 0.03%, CaCO3 0.05%, KH2PO40.03%, surplus is water, and the content of each ingredient presses mass volume ratio;
3) fermented and cultured:The seed fermentation liquid obtained after step 2) fermentation is moved into bulk fermentation tank and is cultivated, setting fermentation ginseng Number is:Ventilation ratio 1:1, mixing speed 420rpm, 40 DEG C of fermentation temperature, 30~32hr of incubation time, the ingredient of fermentation medium For:Rice meal 6.5%, starch 4%, corn flour 2.5%, dregs of beans 2.5%, NaCl 0.03%, CaCO30.03%, KH2PO4 0.03%, defoaming agent 0.01%, surplus is water, and the content of each ingredient presses mass volume ratio, is obtained after fermentation containing well The fermentation liquid of ridge mycin.
CN201510963611.0A 2015-12-21 2015-12-21 One plant of jute streptomycete for producing jinggangmeisu and its application Active CN105543125B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510963611.0A CN105543125B (en) 2015-12-21 2015-12-21 One plant of jute streptomycete for producing jinggangmeisu and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510963611.0A CN105543125B (en) 2015-12-21 2015-12-21 One plant of jute streptomycete for producing jinggangmeisu and its application

Publications (2)

Publication Number Publication Date
CN105543125A CN105543125A (en) 2016-05-04
CN105543125B true CN105543125B (en) 2018-11-27

Family

ID=55822683

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510963611.0A Active CN105543125B (en) 2015-12-21 2015-12-21 One plant of jute streptomycete for producing jinggangmeisu and its application

Country Status (1)

Country Link
CN (1) CN105543125B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106755213B (en) * 2016-12-23 2020-06-19 武汉科诺生物科技股份有限公司 Validamycin fermentation process

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662898A (en) * 1990-08-20 1997-09-02 Ciba-Geigy Corporation Genes for the synthesis of antipathogenic substances
CN102010835A (en) * 2010-07-27 2011-04-13 江苏丘陵地区镇江农业科学研究所 Streptomyces corchorusii strain NF0919, purpose and preparation method of active zymotic fluid thereof
CN103937856A (en) * 2014-04-21 2014-07-23 浙江大学 Fermentation method capable of enhancing validamycin yield

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662898A (en) * 1990-08-20 1997-09-02 Ciba-Geigy Corporation Genes for the synthesis of antipathogenic substances
CN102010835A (en) * 2010-07-27 2011-04-13 江苏丘陵地区镇江农业科学研究所 Streptomyces corchorusii strain NF0919, purpose and preparation method of active zymotic fluid thereof
CN103937856A (en) * 2014-04-21 2014-07-23 浙江大学 Fermentation method capable of enhancing validamycin yield

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Butalactin: a new butanolide antibiotic from streptomyces corchorusii;Sugata Chatterjee等;《Tetrahedron Letters》;19910101;第32卷(第1期);141-144 *
黄麻链霉菌NF0919菌株发酵提取液HPLC 检测分析及稳定性研究;张文文 等;《中国农学通报》;20141231;第30卷(第33期);145-149 *

Also Published As

Publication number Publication date
CN105543125A (en) 2016-05-04

Similar Documents

Publication Publication Date Title
CN102864111B (en) Schizochytrium limacinum strain for producing docosahexaenoic acid
CN106399152B (en) The inhibited streptomycete of a kind of pair of soybean phytophthora root rot germ, biological prevention and control agent and preparation method thereof
CN111500489B (en) Bacillus coagulans and application thereof in tea planting
CN109721425A (en) A kind of dedicated phylloplane organisms bacterial manure of rice and preparation method thereof
CN109251879A (en) A kind of Jie meter La series bacillus fermentation process in high density
CN105316255B (en) A kind of method of soil beneficial microbe mixed fermentation
CN102154194B (en) Preparation method for high-yield chlamydospore liquid fermentation from trichoderma on pilot plant test scale
CN103602593A (en) Paecilomyces lilacinus space mutation mutant strain Sd-m-16 and microbial preparation and application thereof
CN105754890B (en) One plant of streptomyces hygroscopicus for producing jinggangmeisu and its application
CN105494447B (en) Biological seed coating agent and its preparation method and application for controlling soybean root disease
CN109609491A (en) It is a kind of it is efficient produce kasugarnycin streptomyces microaureus mutagenesis and screening technique
CN102766663B (en) Preparation method of active polysaccharides from phellinus linteus
CN110093283A (en) Strain of Beauveria bassiana and its cultural method
CN105543125B (en) One plant of jute streptomycete for producing jinggangmeisu and its application
CN108841889A (en) The main part of Songgangmeisu --- the method for griseofulvin is produced using microbial fermentation
CN108823110A (en) One plant of bacterial strain for producing griseofulvin and its application
CN104726379B (en) The superior strain W 273 of one plant of biological pesticide Wuyiencin and its application
CN102093962A (en) Lactococcus lactis induced strain and breeding method thereof
CN104877914B (en) A kind of high yield Hericium erinaceus mutagenic strain H07 and preparation method
CN106520554A (en) High-throughput screening method for obtaining apramycin high-yield strain
CN103333846A (en) Organic material decomposition agent
CN109112171A (en) A kind of preparation method of the antibacterial substance based on marine microorganism
CN104195076A (en) Bacillus methylotrophicus Sanju-04 and application thereof
CN107557311B (en) Lactobacillus acidophilus and application thereof in fermentation production of antibacterial polypeptide
CN108531404A (en) One plant of layer goes out cultural method and its application of Fusariumsp

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant